Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.34% Nasdaq Up0.16%

PharmAthene, Inc. (PIP)

-NYSE MKT

1.64 May 21, 4:01PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 6,475   6,014   6,696   6,317  
Cost of Revenue -   -   -   -  
Gross Profit 6,475   6,014   6,696   6,317  
Operating Expenses
Research Development5,233  4,747  5,139  4,919  
Selling General and Administrative2,280  2,625  3,275  2,780  
Non Recurring -   -   -   -  
Others53  69  72  76  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (1,091) (1,427) (1,790) (1,458)
Income from Continuing Operations
Total Other Income/Expenses Net(911)280  1,711  829  
Earnings Before Interest And Taxes(2,002)(1,147)(79)(629)
Interest Expense100  116  113  111  
Income Before Tax(2,102)(1,263)(192)(740)
Income Tax Expense10  7  22  16  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,111)(1,270)(214)(757)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,111) (1,270) (214) (757)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,111) (1,270) (214) (757)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.